Formal Signing of the Tetrahedral Framework Nucleic Acid Industry-Academia-Research Base Co-construction Project

On April 28, 2024, Yunhai Biotechnology, the Chengdu Jinniu District People's Government, and the State Key Laboratory of Oral Diseases (hereinafter referred to as the "State Key Laboratory") held a grand signing ceremony in Chengdu's Jinniu District. The three parties jointly signed the "Agreement on the Co-construction of the Tetrahedral Framework Nucleic Acid Industry-Academia-Research Base Project," marking a significant step forward in the field of biotechnology, particularly in nucleic acid drug development.

The nucleic acid drug delivery system, led by Professor Yunfeng Lin's team from the State Key Laboratory, has broken the long-standing foreign technology and patent barriers in this field, becoming China's leading and independently controllable "Chinese solution" and "Chinese technology." This achievement fills a long-standing gap in China's industry-academia-research integration in this area. The technology has already completed industrialization validation in multiple application fields, with promising future application scenarios.